Prescription drug · BLA
Plegridy Pen (Peginterferon beta-1a) NDC 64406-011
Peginterferon beta-1a 125 ug/.5mL · Injection, Solution · Subcutaneous · Biogen Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 64406-011-01 | 6440600110164406001101 | 1 TRAY in 1 CARTON (64406-011-01) / 2 SYRINGE in 1 TRAY / .5 mL in 1 SYRINGE (64406-011-02)Marketed from Aug 15, 2014 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Plegridy PenSuffix: Pen
- Generic name (nonproprietary)
- peginterferon beta-1a
- Active ingredients
- Peginterferon beta-1a — 125 ug/.5mL
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Labeler
- Biogen Inc.NDC labeler code 64406
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125499
- Marketing start
- Listing expires
- Other FDA classes
- Interferon-beta (Chemical structure)
- Identifiers
- Product ID 64406-011_82966338-6ae8-490e-8f3a-f94f558fb43fSPL ID 82966338-6ae8-490e-8f3a-f94f558fb43fSPL set ID 08f0ea03-4e6d-195d-aef4-886e32befa95RxCUI 1546172, 1546177, 1546181, 1546183, 1546187, 1546189, 1546197, 1546198, 1649591, 1649593, 1649600, 1649601, 1649602, 1649603, 1649604, 1649605UNII I8309403R0
- Pharmacologic class
- Interferon beta
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N464406001101followed by a unit qualifier and the quantityPackage 64406-0011-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
PLEGRIDY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. PLEGRIDY is an interferon beta indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 64406-011
- What is NDC 64406-011?
- 64406-011 is the product NDC for Plegridy Pen (peginterferon beta-1a), Peginterferon beta-1a 125 ug/.5mL injection, solution, listed with the FDA by Biogen Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Plegridy Pen (Peginterferon beta-1a).
- What is the active ingredient?
- Peginterferon beta-1a.
- Who is the labeler?
- Biogen Inc., NDC labeler code 64406. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Plegridy Pen?
- 1 other product NDC are listed under this name. See all Plegridy Pen NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Plegridy Pen products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Plegridy Penpeginterferon beta-1a | — | KitSubcutaneous | Biogen Inc. | 64406-012 | 64406-0012-01 |
Other NDCs under BLA 125499
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Plegridypeginterferon beta-1a | Peginterferon beta-1a 125 ug/.5mL | Injection, SolutionSubcutaneous | Biogen Inc. | 64406-015 |
| Plegridypeginterferon beta-1a | — | KitSubcutaneous | Biogen Inc. | 64406-016 |
| Plegridypeginterferon beta-1a | Peginterferon beta-1a 125 ug/.5mL | Injection, SolutionIntramuscular | Biogen Inc. | 64406-017 |
| Plegridy Penpeginterferon beta-1a | — | KitSubcutaneous | Biogen Inc. | 64406-012 |